First published 10/3/2026, 1:28:15 AM · Last updated 10/3/2026, 1:28:15 AM

MO28-6 Operational issues and solutions for DCTs in investigator-initiated registration-directed trials in oncology

A journal article presents operational issues and proposed solutions for decentralized clinical trials used in investigator-initiated registration-directed oncology studies. The source record is a journal article published by Elsevier BV.

Illustrative image: Chicago, IL - 2018 ASCO Annual Meeting - Recipients during 2018 Grants & Awards Ceremony and Reception at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Sunday June 3, 2018. Approximately 40,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 54th Annual Meeting, which is being held at McCormick Place. The ASCO Annual Meeting highlights the latest findings in all major areas of oncology, from basic to clinical and epide — Alexdasg/Wikimedia Commons, CC BY-SA 4.0

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 3/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

It addresses operational challenges and solutions relevant to the conduct of oncology clinical trials.

Sources

MO28-6 Operational issues and solutions for DCTs in investigator-initiated registration-directed trials in oncology

Report an issue